Clinical trials
During the study period, a majority of clinical trials (64%, 25 of 39) run through the head and neck multidisciplinary group were put on hold. Our institution continues to place a high value on advancing cancer care, and select trials remain open. For head and neck cancer patients, selected trials were prioritized to stay open based on the opportunity to deliver novel therapy and/or defer surgical intervention. Trials recommended to stay open included 6 immunotherapy protocols, and 4 radiation therapy protocols. For trials that remain open, selected research procedures including consent were IRB-approved for remote management on an individual trial basis. Translational analysis of all specimens is currently on hold.